Overview

A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin

Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
To examine the effect of three different blood pressure medications on the insulin sensitivity in overweight patients with high blood pressure.
Phase:
Phase 4
Details
Lead Sponsor:
Daiichi Sankyo Inc.
Daiichi Sankyo, Inc.
Treatments:
Atenolol
Losartan
Olmesartan
Olmesartan Medoxomil